IOL Chemicals and Pharmaceuticals Limited
NSE: IOLCP BSE: IOLCP
NSE
103.16
2.87 (2.86%)
Prev Close
100.29
Open Price
98.69
Volume
5,353,453
Today Low / High
97.45 / 104.9
52 WK Low / High
57.5 / 107.54
Range
98 - 108
BSE
103.08
2.88 (2.87%)
Prev Close
100.2
Open Price
93.82
Volume
471,373
Today Low / High
93.82 / 105
52 WK Low / High
57.51 / 107.41
Range
98 - 108
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 103.16 (target range: 98 - 108), reflecting a change of 2.87 (2.8617%). On the BSE, it is listed at 103.08 (target range: 98 - 108), showing a change of 2.88 (2.87425%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
30 Jul
93.70
7.03%
29 Jul
92.06
1.15%
28 Jul
93.97
-1.69%
25 Jul
95.55
-1.38%
24 Jul
99.32
-3.51%
23 Jul
96.40
2.33%
22 Jul
98.40
-2.03%
21 Jul
91.50
7.03%
18 Jul
92.69
-0.96%
17 Jul
93.55
-1.17%
16 Jul
93.40
0.02%
15 Jul
93.31
0.28%
14 Jul
91.26
1.67%
11 Jul
91.05
0.14%
10 Jul
91.20
-0.16%
09 Jul
91.52
-0.93%
08 Jul
94.34
-2.49%
07 Jul
94.00
0.70%
04 Jul
93.41
0.25%
03 Jul
95.96
-2.66%
IOL Chemicals and Pharmaceuticals Limited Graph
IOL Chemicals and Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for IOL Chemicals and Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 103.16, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 103.08 | 104.11 | 93.70 - 114.52 |
| 105.14 | 84.11 - 126.17 | ||
| 106.17 | 74.32 - 138.02 | ||
| Bearish Scenario | 103.08 | 102.05 | 91.84 - 112.25 |
| 101.02 | 80.81 - 121.22 | ||
| 99.99 | 69.99 - 129.98 |
Overview of IOL Chemicals and Pharmaceuticals Limited
ISIN
INE485C01011
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
1,523,930
Market Cap
29,437,822,830
Last Dividend
0.8
Official Website
IPO Date
2010-11-08
DCF Diff
95.39
DCF
5
Financial Ratios Every Investor Needs
Stock Dividend of IOLCP
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-02-18 | February 18, 25 | 0.8 | 4 | 2025-02-18 | 2025-03-14 | |
| 2024-02-16 | February 16, 24 | 5 | 125 | 2024-02-16 | 2024-03-07 | |
| 2023-02-17 | February 17, 23 | 0.8 | 20 | 2023-02-17 | 2023-03-08 | |
| 2022-02-15 | February 15, 22 | 0.8 | 20 | 2022-02-16 | 2022-03-05 | |
| 2021-09-08 | September 08, 21 | 0.4 | 10 | 2021-09-11 | 2021-10-18 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2,079.21 Cr | 1,680.41 Cr | 687.36 Cr | 0.3306 | 0.00 Cr | 0.00 Cr | 130.31 Cr | 101.07 Cr | 3.44 | 224.71 Cr | 0.0486 |
| 2024-03-31 | 2,132.79 Cr | 1,418.47 Cr | 714.32 Cr | 0.3349 | 0.00 Cr | 6.69 Cr | 167.93 Cr | 134.43 Cr | 22.90 | 260.66 Cr | 0.0630 |
| 2023-03-31 | 2,201.69 Cr | 1,560.54 Cr | 641.15 Cr | 0.2912 | 16.75 Cr | 5.83 Cr | 180.17 Cr | 139.14 Cr | 23.70 | 245.50 Cr | 0.0632 |
| 2022-03-31 | 2,168.37 Cr | 1,596.66 Cr | 571.71 Cr | 0.2637 | 11.14 Cr | 4.50 Cr | 216.19 Cr | 167.67 Cr | 28.56 | 270.54 Cr | 0.0773 |
| 2021-03-31 | 1,946.14 Cr | 1,124.17 Cr | 821.97 Cr | 0.4224 | 6.36 Cr | 4.05 Cr | 553.07 Cr | 444.56 Cr | 76.21 | 611.25 Cr | 0.2284 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 78.17 Cr | 2,382.07 Cr | 694.41 Cr | 1,687.6600 Cr | 117.04 Cr | 38.87 Cr | 360.62 Cr | 1,179.18 Cr | 0.00 Cr | 0.00 Cr | 25.29 Cr | 609.9100 Cr |
| 2024-03-31 | 7.69 Cr | 2,244.40 Cr | 632.89 Cr | 1,611.5100 Cr | 32.76 Cr | 25.07 Cr | 424.84 Cr | 1,021.39 Cr | 0.00 Cr | 0.00 Cr | -39.10 Cr | 560.0000 Cr |
| 2023-03-31 | 1.39 Cr | 2,022.13 Cr | 514.41 Cr | 1,507.7200 Cr | 79.81 Cr | 78.42 Cr | 325.52 Cr | 832.56 Cr | 0.00 Cr | 0.00 Cr | 248.15 Cr | 456.2600 Cr |
| 2022-03-31 | 3.23 Cr | 1,962.30 Cr | 570.02 Cr | 1,392.4800 Cr | 43.95 Cr | 40.72 Cr | 409.89 Cr | 662.49 Cr | 0.00 Cr | 0.00 Cr | 203.71 Cr | 513.4000 Cr |
| 2021-03-31 | 32.34 Cr | 1,610.09 Cr | 349.66 Cr | 1,260.4300 Cr | 2.73 Cr | -29.61 Cr | 295.15 Cr | 560.42 Cr | 4.04 Cr | 0.00 Cr | 19.68 Cr | 290.5500 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 178.6200 Cr | -154.1800 Cr | 46.0400 Cr | -34.9300 Cr | 70.4800 Cr | 78.1700 Cr | -213.5500 Cr | 137.9600 Cr | 84.2800 Cr | -23.4800 Cr | 64.2200 Cr |
| 2024-03-31 | 290.0800 Cr | -191.2800 Cr | -92.5000 Cr | 15.9100 Cr | 6.3000 Cr | 7.6900 Cr | -274.1700 Cr | 134.4300 Cr | -46.8700 Cr | -29.3500 Cr | -99.3200 Cr |
| 2023-03-31 | 122.2700 Cr | -120.0000 Cr | -4.1100 Cr | -89.5500 Cr | -1.8400 Cr | 1.3900 Cr | -211.8200 Cr | 188.6500 Cr | 36.8800 Cr | -23.5000 Cr | 84.3700 Cr |
| 2022-03-31 | 93.0500 Cr | -120.5200 Cr | -1.6400 Cr | -60.2400 Cr | -29.1100 Cr | 3.2300 Cr | -153.2900 Cr | 224.8500 Cr | 42.7500 Cr | -35.2200 Cr | -114.7500 Cr |
| 2021-03-31 | 379.7800 Cr | -317.2500 Cr | -58.2800 Cr | 271.5700 Cr | 4.2500 Cr | 32.3400 Cr | -108.2100 Cr | 571.3900 Cr | -57.5300 Cr | -23.4800 Cr | -107.6200 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 527.78 Cr | 345.79 Cr | 181.99 Cr | 0.3448 | 44.20 Cr | 31.42 Cr | 0.36 | 67.28 Cr | 0.0595 |
| 2024-12-31 | 523.30 Cr | 354.05 Cr | 169.25 Cr | 0.3234 | 28.19 Cr | 20.53 Cr | 3.50 | 50.94 Cr | 0.0392 |
| 2024-09-30 | 525.75 Cr | 355.64 Cr | 170.11 Cr | 0.3236 | 23.63 Cr | 19.15 Cr | 3.26 | 48.00 Cr | 0.0364 |
| 2024-06-30 | 502.38 Cr | 336.37 Cr | 166.01 Cr | 0.3304 | 34.29 Cr | 29.97 Cr | 5.11 | 58.49 Cr | 0.0597 |
| 2024-03-31 | 503.92 Cr | 388.60 Cr | 115.32 Cr | 0.2288 | 33.09 Cr | 27.62 Cr | 4.71 | 51.78 Cr | 0.0548 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 78.17 Cr | 3.30 Cr | 217.08 Cr | 513.69 Cr | 360.62 Cr | 1,151.34 Cr | 1,179.18 Cr | 2,382.07 Cr | 694.41 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 154.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,659.28 Cr |
| 2024-09-30 | 18.38 Cr | 140.94 Cr | 159.32 Cr | 464.56 Cr | 375.68 Cr | 1,085.68 Cr | 1,120.47 Cr | 2,265.10 Cr | 605.82 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 115.05 Cr | 0.00 Cr | 0.00 Cr | 115.05 Cr | 0.00 Cr | 0.00 Cr | -1,611.51 Cr |
| 2024-03-31 | 7.69 Cr | 108.26 Cr | 115.95 Cr | 471.23 Cr | 424.84 Cr | 1,119.77 Cr | 1,021.39 Cr | 2,244.40 Cr | 632.89 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 31.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 20.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 19.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 29.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 27.62 Cr | 65.17 Cr | -31.26 Cr | -31.68 Cr | 2.23 Cr | 2.23 Cr | 0.00 Cr | -80.13 Cr | -14.96 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2025-03-11 | March 11, 25 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,706.70 | ₹4,094,851,176,000.00 | ₹3,230,078.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,595.50 | ₹1,750,900,789,500.00 | ₹208,221.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,741.90 | ₹1,266,427,345,500.00 | ₹261,642.00 |
| Mankind Pharma Limited | MANKIND | ₹2,567.20 | ₹1,059,557,272,672.00 | ₹454,636.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,270.30 | ₹1,057,311,434,873.00 | ₹1,968,798.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹969.80 | ₹975,841,854,000.00 | ₹1,184,140.00 |
| Lupin Limited | LUPIN | ₹1,929.10 | ₹881,110,637,700.00 | ₹1,105,279.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,137.80 | ₹660,836,515,600.00 | ₹5,489,663.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,134.10 | ₹602,245,154,100.00 | ₹992,818.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,031.10 | ₹601,543,471,500.00 | ₹118,281.00 |
| Laurus Labs Limited | LAURUSLABS | ₹874.35 | ₹471,772,155,150.00 | ₹3,032,532.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹998.45 | ₹381,974,029,138.00 | ₹410,439.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,473.90 | ₹373,934,325,600.00 | ₹302,398.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,751.40 | ₹343,682,876,800.00 | ₹77,148.00 |
| Piramal Enterprises Limited | PEL | ₹1,251.80 | ₹283,755,520,400.00 | ₹2,308,743.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,769.30 | ₹276,573,437,400.00 | ₹284,299.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,667.50 | ₹270,933,732,500.00 | ₹282,417.00 |
| Eris Lifesciences Limited | ERIS | ₹1,798.90 | ₹245,004,783,300.00 | ₹52,393.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,186.00 | ₹229,650,000,000.00 | ₹15,858.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹977.90 | ₹192,218,957,700.00 | ₹54,884.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,194.10 | ₹190,197,442,100.00 | ₹370,820.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹953.40 | ₹170,763,474,000.00 | ₹430,795.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,281.00 | ₹170,393,901,900.00 | ₹72,413.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,066.40 | ₹157,070,576,880.00 | ₹60,750.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹474.90 | ₹115,231,635,600.00 | ₹940,401.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,918.50 | ₹98,243,548,900.00 | ₹6,998.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹888.25 | ₹86,862,766,925.00 | ₹105,636.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹911.20 | ₹82,586,265,744.00 | ₹287,584.00 |
| Strides Pharma Science Limited | STAR | ₹874.10 | ₹80,559,416,070.00 | ₹774,363.00 |
| FDC Limited | FDC | ₹479.35 | ₹78,042,973,500.00 | ₹94,963.00 |
| Suven Life Sciences Limited | SUVEN | ₹272.37 | ₹59,396,815,380.00 | ₹127,697.00 |
| Innova Captab Limited | INNOVACAP | ₹909.35 | ₹52,037,490,096.00 | ₹29,685.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹150.54 | ₹48,853,541,880.00 | ₹152,010.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹506.75 | ₹46,251,072,500.00 | ₹306,148.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹623.45 | ₹43,894,496,010.00 | ₹55,475.00 |
| Sequent Scientific Limited | SEQUENT | ₹171.97 | ₹43,050,109,950.00 | ₹363,036.00 |
| Hikal Limited | HIKAL | ₹323.10 | ₹39,838,553,100.00 | ₹170,616.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹397.10 | ₹39,820,393,800.00 | ₹123,432.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,401.00 | ₹39,710,139,000.00 | ₹24,441.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹740.40 | ₹37,552,421,640.00 | ₹56,665.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹58.45 | ₹32,027,911,300.00 | ₹1,497,181.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹641.85 | ₹30,907,003,050.00 | ₹88,498.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹103.16 | ₹30,280,245,320.00 | ₹5,353,453.00 |
| Indoco Remedies Limited | INDOCO | ₹317.85 | ₹29,320,995,015.00 | ₹63,895.00 |
| Alembic Limited | ALEMBICLTD | ₹112.12 | ₹28,790,397,728.00 | ₹257,904.00 |
Key Executives
President of Engineering
Mr. Gopal Singla
Gender: male
Year Born: 1976
Director of Works & Wholetime Director
Mr. Kushal Kumar Rana
Gender: male
Year Born: 1969
President of R&D
Mr. Kamlesh Jayantilal Ranbhan
Gender: male
Year Born: 1965
President of Project
Mr. Damandeep Singh
Gender: male
Year Born: 1974
Joint Managing Director & Executive Director
Mr. Vikas Gupta
Gender: male
Year Born: 1992
Executive Director
Mr. Abhiraj Gupta
Gender: male
Year Born:
Vice President, Company Secretary & Compliance Officer
Mr. Abhay Raj Singh
Gender: male
Year Born:
Chief Financial Officer
Mr. Pardeep Kumar Khanna
Gender: male
Year Born: 1970
Chief Technology Officer
Dr. Gurupur Ganesh Pai
Gender: Not Specified
Year Born: 1952
MD & Whole Time Director
Mr. Varinder Gupta
Gender: male
Year Born: 1962
FAQs about IOL Chemicals and Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Pardeep Kumar Khanna.
What is the current market price of the stock?
The current price is ₹100.29.
What is the 52-week price range?
The range is ₹57.5-107.54.
What is the market capitalization of the company?
The market capitalization is ₹2,943.78 crores.
What is the dividend yield?
The dividend yield is 0.80%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 87.44.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of IOL Chemicals and Pharmaceuticals Limited (ISIN: INE485C01011) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹2,943.78 crores and an average daily volume of 1,523,930 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.8.